| (Values in U.S. Thousands) | Nov, 2022 | Nov, 2021 | Nov, 2020 | Nov, 2019 | Nov, 2018 |
| Sales | 280 | 200 | 30 | 0 | 0 |
| Sales Growth | +40.00% | +566.67% | unch | unch | unch |
| Net Income | -2,050 | -8,240 | -13,490 | -10,280 | -9,270 |
| Net Income Growth | +75.12% | +38.92% | -31.23% | -10.90% | +36.24% |
Q Biomed Inc (QBIO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0001 -0.0001 (-50.00%) 03/14/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0001 unch (unch) 15:54 ET
for Fri, Mar 14th, 2025
Q BioMed Inc. is a biomedical acceleration and development company. It focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. Q BioMed Inc. is based in New York.
Fiscal Year End Date: 11/30